Core Scientific (CORZ) Equity Ratio (2020 - 2026)

Core Scientific has disclosed Equity Ratio across 7 years of filings, most recently posting 0.43 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.43, down 106.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.43 (down 106.34% YoY), and the FY2025 annual result was 0.41, up 35.82% from the prior year.
• Equity Ratio came in at 0.43 for Q1 2026 at Core Scientific, down from 0.41 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.42 in Q1 2022 to a low of 1.78 in Q2 2024.
• The 5-year median for Equity Ratio is 0.52 (2023), against an average of 0.49.
• Across the five-year window, Equity Ratio soared 135.38% in 2022 and tumbled 1241.14% in 2023, its largest moves.
• Core Scientific's Equity Ratio stood at 0.51 in 2022, then tumbled by 65.39% to 0.84 in 2023, then advanced by 23.77% to 0.64 in 2024, then soared by 35.82% to 0.41 in 2025, then dropped by 3.73% to 0.43 in 2026.
• The last three Equity Ratio figures came in at 0.43 (Q1 2026), 0.41 (Q4 2025), and 0.58 (Q3 2025), per Business Quant data.